Oesch F, Schladt L
Pharmacol Ther. 1987;33(1):29-35. doi: 10.1016/0163-7258(87)90024-6.
The effect of four hypolipidemic compounds (tiadenol, clofibrate, acetylsalicylic acid, 1-benzylimidazole) on the specific activities of peroxisomal beta-oxidation and cytosolic and microsomal epoxide hydrolase of rat liver was investigated. Since specific activity of cytosolic epoxide hydrolase from outbred Sprague-Dawley rats showed large interindividual variations (approximately 38-fold), induction studies were performed with inbred Fischer F-344 rats, which showed only low interindividual variations (approximately 2-fold). Clofibrate, tiadenol and acetylsalicylic acid caused a 8-, 13- and 4.5-fold induction of cEH and a 13-, 19- and 5-fold induction of peroxisomal beta-oxidation activity, respectively. Microsomal epoxide hydrolase activity was only slightly increased (less than 1.5-fold). 1-Benzylimidazole induced both cytosolic epoxide hydrolase and peroxisomal beta-oxidation activity about 2-fold, whereas microsomal epoxide hydrolase activity was increased about 4-fold. Increase in cytosolic epoxide hydrolase activity was not due to enzyme activation as demonstrated by in vitro studies. On the other hand, these in vitro studies showed that the increase in microsomal epoxide hydrolase activity by 1-benzylimidazole may partially be due to activation of the enzyme.
研究了四种降血脂化合物(替阿地诺、氯贝丁酯、乙酰水杨酸、1-苄基咪唑)对大鼠肝脏过氧化物酶体β-氧化以及胞质和微粒体环氧化物水解酶比活性的影响。由于远交系斯普拉格-道利大鼠的胞质环氧化物水解酶比活性存在较大的个体间差异(约38倍),因此使用近交系费希尔F-344大鼠进行诱导研究,该品系大鼠仅表现出较低的个体间差异(约2倍)。氯贝丁酯、替阿地诺和乙酰水杨酸分别使胞质环氧化物水解酶诱导8倍、13倍和4.5倍,使过氧化物酶体β-氧化活性诱导13倍、19倍和5倍。微粒体环氧化物水解酶活性仅略有增加(小于1.5倍)。1-苄基咪唑使胞质环氧化物水解酶和过氧化物酶体β-氧化活性均诱导约2倍,而微粒体环氧化物水解酶活性增加约4倍。体外研究表明,胞质环氧化物水解酶活性的增加并非由于酶的激活。另一方面,这些体外研究表明,1-苄基咪唑使微粒体环氧化物水解酶活性增加可能部分归因于该酶的激活。